General Range
FORAXIME 200 DT
Price on request/100 · MOQ 100 boxes
FORAXIME 200 DT Tablets by Fortune Labs contain Cefixime 200 mg, a third-generation cephalosporin antibiotic used to treat various bacterial infections caused by susceptible microorganisms. Cefixime works by inhibiting bacterial cell wall synthesis, helping eliminate infection-causing bacteria. FORAXIME 200 DT may be prescribed for selected respiratory tract infections, throat infections, urinary tract infections, and typhoid fever when clinically appropriate. Its dispersible tablet formulation provides a convenient administration option under medical guidance. Available in 10 × 10 tablet blister packaging, FORAXIME 200 DT is part of Fortune Labs' pharmaceutical portfolio. Fortune Labs offers PCD Pharma Franchise and distribution opportunities across India. Contact the company for wholesale pricing, product availability, and franchise enquiries. Use only as prescribed by a healthcare professional.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Cefixime 200 mg
- Packaging Type
- Blister Pack
- Packaging Size
- 10 × 10
- Dosage Form
- Tablet
- Treatment
- Bacterial respiratory tract infections, throat infections, urinary tract infections, typhoid fever, and other infections caused by susceptible bacteri
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
